Bausch Health Companies (BHC) Dividend Coverage Ratio Growth (3y) (2012 - 2013)
Analysis
Bausch Health Companies (BHC) Dividend Coverage Ratio Growth (3y) (2012 - 2013) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.81 Bn | 39.16 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn | -35.05% |
| 3 | Dr Reddys Laboratories | 9.90 Bn | 9.73 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.32 Bn | 479.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.12 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 997.70 Mn | 707.58 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 395.89 Mn | 354.64 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 179.21 Mn | 179.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2013 | -10,653.95% |
| Sep 30, 2013 | -222.58% |
| Dec 31, 2012 | -186.11% |